Last reviewed · How we verify
Duvie (LOBEGLITAZONE)
Duvie (generic name: LOBEGLITAZONE) is a Small molecule drug developed by Chong Kun Dang. It is currently FDA-approved for Diabetes mellitus type 2.
Duvie is a small molecule medication used to treat type 2 diabetes mellitus. It is often studied in combination with other medications, such as Januvia, in clinical trials.
At a glance
| Generic name | LOBEGLITAZONE |
|---|---|
| Sponsor | Chong Kun Dang |
| Target | Peroxisome proliferator-activated receptor gamma |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Diabetes mellitus type 2
Common side effects
Key clinical trials
- Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers (PHASE1)
- Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers (PHASE1)
- Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy Volunteers (PHASE1)
- Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors (PHASE4)
- Pharmacokinetics and Safety of M107 Orally Disintegrating Tablet in Healthy Adults (PHASE1)
- To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers (PHASE1)
- Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State. (PHASE1)
- Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Duvie CI brief — competitive landscape report
- Duvie updates RSS · CI watch RSS
- Chong Kun Dang portfolio CI
Frequently asked questions about Duvie
What is Duvie?
What is Duvie used for?
Who makes Duvie?
What is the generic name of Duvie?
What development phase is Duvie in?
What does Duvie target?
Related
- Target: All drugs targeting Peroxisome proliferator-activated receptor gamma
- Manufacturer: Chong Kun Dang — full pipeline
- Therapeutic area: All drugs in Metabolic
- Indication: Drugs for Diabetes mellitus type 2
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing